S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom

Neighbourly Pharmacy (NBLY) Stock Forecast & Price Target

Neighbourly Pharmacy Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 6 Analyst Ratings

Analysts' Consensus Price Target

C$20.93
High ForecastC$28.00
Average ForecastC$20.93
Low ForecastC$18.50
TypeCurrent Forecast
4/19/23 to 4/18/24
1 Month Ago
3/20/23 to 3/19/24
3 Months Ago
1/19/23 to 1/19/24
1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$20.93C$20.93C$22.50C$27.42
Predicted UpsideN/A24.01% Upside34.08% Upside23.40% Upside
Get Neighbourly Pharmacy Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NBLY and its competitors with MarketBeat's FREE daily newsletter.

NBLY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NBLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Neighbourly Pharmacy Stock vs. The Competition

TypeNeighbourly PharmacyMedical Companies
Consensus Rating Score
2.33
2.68
Consensus RatingHoldModerate Buy
News Sentiment RatingNeutral News
Neutral News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/14/2024Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHoldC$20.00 ➝ C$18.50+0.71%
2/14/2024TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Sector PerformC$28.00 ➝ C$18.50+0.71%
1/15/2024National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform ➝ TenderC$20.50 ➝ C$18.50+1.54%
12/19/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket PerformC$18.50 ➝ C$20.50+36.76%
12/19/2023Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$20.50 ➝ C$18.50+23.42%
8/2/2023Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperformC$24.50 ➝ C$24.00+39.45%
7/13/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperformC$34.00 ➝ C$28.00+77.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:01 AM ET.

NBLY Price Target - Frequently Asked Questions

What is Neighbourly Pharmacy's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Neighbourly Pharmacy stock is Hold based on the current 4 hold ratings and 2 buy ratings for NBLY. The average twelve-month price prediction for Neighbourly Pharmacy is C$20.93 with a high price target of C$28.00 and a low price target of C$18.50. Learn more on NBLY's analyst rating history.

Do Wall Street analysts like Neighbourly Pharmacy more than its competitors?

Analysts like Neighbourly Pharmacy less than other Medical companies. The consensus rating for Neighbourly Pharmacy is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how NBLY compares to other companies.

Is Neighbourly Pharmacy being downgraded by Wall Street analysts?

Over the previous 90 days, Neighbourly Pharmacy's stock had 1 downgrade by analysts.

Does Neighbourly Pharmacy's stock price have much upside?

According to analysts, Neighbourly Pharmacy's stock has a predicted upside of 24.01% based on their 12-month stock forecasts.

What analysts cover Neighbourly Pharmacy?

Neighbourly Pharmacy has been rated by Desjardins, and TD Securities in the past 90 days.


Stock Ratings Reports and Tools

This page (TSE:NBLY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners